IMIPRAMINE IN DEPRESSION : A CONTROLLED STUDY
Abstract
The antidepressant drug imipramine was evaluated by means of a double blind study. Therapeutic results were assessed on the basis of a rating scale, psychological tests, and clinical course. Differences favoring the drug were found in some of the psychological tests, but in no clinical area were there significant differences between drug and placebo.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
